Expanding the mutational spectrum of LZTR1 in schwannomatosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European Journal of Human Genetics

• Publication date

  2014-10-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ejhg.2014.220PMID 25335493PMCID PMC4463507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rich annotation of DNA sequencing variants by leveraging the Ensembl Variant Effect Predictor with plugins

  2015cited by this paper
• The integrated landscape of driver genomic alterations in glioblastoma

  2013cited by this paper
• Prediction of Mutant mRNA Splice Isoforms by Information Theory‐Based Exon Definition

  2013cited by this paper
• Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria

  2013cited by this paper
• Analysis Tool Web Services from the EMBL-EBI

  2013cited by this paper
• Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas

  2013cited by this paper
• Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis

  2012cited by this paper
• SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse Functions*

  2012cited by this paper
• A framework for variation discovery and genotyping using next-generation DNA sequencing data

  2011cited by this paper
• SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis

  2011cited by this paper
• A new bioinformatics analysis tools framework at EMBL–EBI

  2010cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

  2010cited by this paper
• MutationTaster evaluates disease-causing potential of sequence alterations

  2010cited by this paper
• High‐resolution DNA melting analysis: advancements and limitations

  2009cited by this paper
• Human Splicing Finder: an online bioinformatics tool to predict splicing signals

  2009cited by this paper
• NF2 Mutation Screening by Denaturing High-Performance Liquid Chromatography and High-Resolution Melting Analysis

  2008cited by this paper
• Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis

  2008cited by this paper
• Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis

  2008cited by this paper
• Evidence of a four‐hit mechanism involving SMARCB1 and NF2 in schwannomatosis‐associated schwannomas

  2008cited by this paper
• Clustal W and Clustal X version 2.0

  2007cited by this paper
• Germline mutation of INI1/SMARCB1 in familial schwannomatosis.

  2007cited by this paper
• The BTB-kelch Protein LZTR-1 Is a Novel Golgi Protein That Is Degraded upon Induction of Apoptosis*

  2006cited by this paper
• Management of patients with schwannomatosis: report of six cases and review of the literature.

  2004cited by this paper
• SIFT: predicting amino acid changes that affect protein function

  2003cited by this paper
• Improved Splice Site Detection in Genie

  1997cited by this paper
• Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.

  1997cited by this paper
• Schwannomatosis

  1996cited by this paper

• Optimal Delivery of Pain Management in Schwannomatosis: A Literature Review

  2025cites this paper
• Imaging and pathology correlation in schwannomatosis: insights from a case series

  2025cites this paper
• Molecular pathogenesis of the schwannomatosis genes and genetic testing strategies

  2025cites this paper
• Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis.

  2025cites this paper
• LZTR1 loss-of-function variants associated with café au lait macules with or without freckling

  2024cites this paper
• Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple café-au-lait macules.

  2024cites this paper
• Phenotypic Expansion of Autosomal Dominant LZTR1-Related Disorders with Special Emphasis on Adult-Onset Features

  2024cites this paper
• Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis

  2024cites this paper
• Cranial Nerve Schwannomatosis: A Case Report and Comprehensive Literature Review on a Distinct Variant of Neurofibromatosis

  2024cites this paper
• Increased dosage of wild-type KRAS protein drives KRAS-mutant lung tumorigenesis and drug resistance

  2024cites this paper
• Multiple intracranial schwannomas of the vestibular and trigeminal nerves: Technical note.

  2024cites this paper
• Exploring the Mechanisms and Current Status of Acupuncture in Alleviating Tumor Metabolism and Associated Diseases: Insights from the Central Nervous System and Immune Microenvironment.

  2024cites this paper
• Typical NF2 and LTZR1 mutations are retained in an immortalized human schwann cell model of schwannomatosis

  2024influential citation
• A novel leucine zipper-like transcriptional regulator 1 variant identified in a pair of siblings with familial schwannomatosis

  2024cites this paper
• Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis

  2023cites this paper
• Pan-Cancer Profiling of Intron Retention and Its Clinical Significance in Diagnosis and Prognosis

  2023cites this paper
• Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

  2023cites this paper
• Novel Therapeutic Approaches for KRAS-Mutated Lung Cancer Involving LZTR1 Genetic Alteration

  2023cites this paper
• Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications

  2023cites this paper
• ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis

  2022cites this paper
• Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore

  2022cites this paper
• De novo CLCN3 variants affecting Gly327 cause severe neurodevelopmental syndrome with brain structural abnormalities

  2022cites this paper
• Clinical Findings in Children with Noonan Syndrome—A 17-Year Retrospective Study in an Oral Surgery Center

  2022cites this paper
• LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis

  2022cites this paper
• WP1066 induces cell death in a schwannomatosis patient–derived schwannoma cell line

  2022cites this paper
• Comparison of the frequency of loss‐of‐function LZTR1 variants between schwannomatosis patients and the general population

  2022influential citation
• Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development

  2021cites this paper
• Genetics of Nerve Tumors

  2021cites this paper
• Pediatric Surgical Pathology of Head and Neck Tumors of the Peripheral Nerve and Paraganglionic System

  2021cites this paper
• Analysis of Imaging and Pathological Features in 12 Cases of Schwannomatosis and Literature Review

  2021cites this paper
• In vivo Functional Genomics for Undiagnosed Patients: The Impact of Small GTPases Signaling Dysregulation at Pan-Embryo Developmental Scale

  2021cites this paper
• Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes

  2021cites this paper
• LZTR1: A promising adaptor of the CUL3 family

  2021cites this paper
• LZTR1 Gene

  2020cites this paper
• LZTR1-related Hypertrophic Cardiomyopathy without Typical Noonan Syndrome Features.

  2020cites this paper
• The Noonan Syndrome Gene Lztr1 Controls Cardiovascular Function by Regulating Vesicular Trafficking

  2020cites this paper
• Cracking the Monoubiquitin Code of Genetic Diseases

  2020cites this paper
• Surgical Management of Multifocal Trigeminal Schwannomas.

  2020cites this paper
• Epigenomic, genomic, and transcriptomic landscape of schwannomatosis

  2020cites this paper
• LZTR1‐related spinal schwannomatosis and 7q11.23 duplication syndrome: A complex phenotype with dual diagnosis

  2020cites this paper
• A Chinese Family with Noonan Syndrome Associated with a Heterozygous LZTR1 Mutation

  2020cites this paper
• Coexistence of schwannomatosis and glioblastoma in two families.

  2019cites this paper
• Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities

  2019cites this paper
• Segmental schwannomatosis: characteristics in 12 patients

  2019cites this paper
• Oligo-astrocytoma in LZTR1-related Noonan syndrome.

  2019cites this paper
• LZTR1: Genotype Expansion in Noonan Syndrome

  2019cites this paper
• In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?

  2019cites this paper
• From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis

  2019cites this paper
• RAS GTPase-dependent pathways in developmental diseases: old guys, new lads, and current challenges.

  2018cites this paper
• Co‐occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1

  2018cites this paper
• Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis

  2018cites this paper
• Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling

  2018cites this paper
• Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination

  2018cites this paper
• Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1–PPP1CB complexes

  2018cites this paper
• Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas

  2018influential citation
• Constitutional LZTR1 mutation presenting with a unilateral vestibular schwannoma in a teenager

  2017cites this paper
• SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome

  2017cites this paper
• Autosomal Recessive Noonan Syndrome Associated with Biallelic LZTR1Variants

  2017cites this paper
• A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas

  2017cites this paper
• Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders

  2017cites this paper
• Further Evidence for the Implication of LZTR1, a Gene not Associated with the Ras-Mapk Pathway, in the Pathogenesis of Noonan Syndrome

  2017cites this paper
• Peripheral nerve sheath tumors: an update and review of diagnostic challenges

  2016cites this paper
• An unusual case of schwannomatosis with bilateral maxillary sinus schwannomas and a novel SMARCB1 gene mutation.

  2016cites this paper
• Pathogenese und Molekularpathologie des Vestibularisschwannoms

  2016cites this paper
• Multiparametric whole‐body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis

  2016cites this paper
• All things rhabdoid and SMARC: An enigmatic exploration with Dr. Louis P. Dehner.

  2016cites this paper
• Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies

  2016cites this paper
• The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis

  2016influential citation
• Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.

  2016cites this paper
• Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

  2016cites this paper
• Biochemical Insights into Merlin/NF2 Pathophysiology and Biologically Targeted Therapies in Childhood NF2 and Related Forms

  2015cites this paper
• Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosis.

  2015cites this paper
• Mosaic Neurocutaneous Disorders and Their Causes.

  2015cites this paper
• Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.

  2015cites this paper
• Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome

  2015cites this paper
• Major Categories of Mosaicism in Human Skin Disorders

  2015cites this paper